Home  »  Market   »  Here’s Why Helix Energy Solutions Group, Inc. (H...

Here’s Why Helix Energy Solutions Group, Inc. (HLX) Is A Stock To Set Your Sights On

On Friday, shares of Helix Energy Solutions Group, Inc. (NYSE:HLX) marked $2.61 per share versus a previous $2.82 closing price. With having a -7.45% loss, an insight into the fundamental values of Helix Energy Solutions Group, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. HLX showed a fall of -72.90% within its YTD performance, with highs and lows between $0.99 – $10.00 during the period of 52 weeks, compared to the simple moving average of -37.96% in the period of the last 200 days.

Piper Sandler equity researchers changed the status of Helix Energy Solutions Group, Inc. (NYSE: HLX) shares from “Neutral” to a “Overweight” rating in the report published on July 23rd, 2020. Other analysts, including BofA/Merrill, also published their reports on HLX shares. BofA/Merrill repeated the rating from the previous report, marking HLX under “Buy” rating, in the report published on May 28th, 2020. Additionally, HLX shares got another “Equal Weight” rating from CapitalOne. On March 13th, 2020, Piper Sandler Downgrade an Neutral rating and increased its price target from $10.75 to $6.25. On the other hand, Raymond James Downgrade the “Outperform” rating for HLX shares, as published in the report on March 10th, 2020. BofA/Merrill seems to be going bullish on the price of HLX shares, based on the price prediction for HLX. Another “Buy” rating came from Johnson Rice.

[bold-text]Helix Energy Solutions Group, Inc. (HLX) Analysis[/bold-text]

The present dividend yield for HLX owners is set at 0, marking the return investors will get regardless of the company’s performance in the upcoming period. However, in order for the company to be able to pay its dividends, just like it is the case with Helix Energy Solutions Group, Inc., the company needs to provide a healthy cash flow, currently at the value of 34.69. In addition, the growth of sales from quarter to quarter is recording -46.00%, hinting the company’s progress in the upcoming progress.

In order to gain a clear insight on the performance of Helix Energy Solutions Group, Inc. (HLX) as it may occur in the future, there are more than several well-rounded types of analysis and research techniques, while equity is most certainly one of the more important indicators into the company’s growth and performance. In this case, you want to make sure that the return on the present equity of 1.80% is enough for you to make a profit out of your investment. You may also count in the quick ratio of the company, currently set at 1.70 so you would make sure that the company is able to cover the debts it may have, which can be easily seen in annual reports of the company.

Set to affect the volatility of a given stock, the average volume can also be a valuable indicator, while HLX is currently recording an average of 2.78M in volumes. The volatility of the stock on monthly basis is set at 8.41%, while the weekly volatility levels are marked at 7.01%with -5.09% of loss in the last seven days.

[bold-text]What to Look for When Analyzing Helix Energy Solutions Group, Inc. Shares?[/bold-text]

Helix Energy Solutions Group, Inc. (HLX) is based in the USA and it represents one of the well-known company operating with Energy sector. If you wish to compare HLX shares with other companies under Electronic Equipment and Consumer Goods, a factor to note is the P/E value of 15.35 for Helix Energy Solutions Group, Inc., while the value can represent an indicator in the future growth of the company in terms of investor’s expectations. The later value should have a steady growth rate, increasing and growing gradually, which serves the purpose of reliably showcasing the progress of the company. The value 0.17 is supported by the yearly EPS growth of 98.50%.

Besides from looking into the fundamentals, you should also note the number of people inside the company owning the shares, as the values should be in line with the expectations of investors. In that spirit, the present ownership of stocks inside the company is set at 0.40%, which can provide you with an insight of how involved executives are in owning shares of the company. In oppose to the executives’ share, the institutional ownership counts 85.20% of shares, carrying an equal significance as an indicator of value, as the presence of large investors may signal a strong company.

[bold-text]Are Institutional Investors Increasing Stakes in HLX Shares?[/bold-text]

It appears that more than several institutional investors and hedge funds decided to increase stakes in HLX in the recent period. That is how BlackRock Fund Advisors now has an increase position in HLX by 2.56% in the first quarter, owning 20.25 million shares of HLX stocks, with the value of $48.81 million after the purchase of an additional 505,619 shares during the last quarter. In the meanwhile, Macquarie Investment Management B also increased their stake in HLX shares changed 2.02% in the first quarter, which means that the company now owns 5.71 million shares of company, all valued at $13.75 million after the acquisition of additional 112,818 shares during the last quarter.

SSgA Funds Management, Inc. acquired a new position in Helix Energy Solutions Group, Inc. during the first quarter, with the value of $13.23 million, and AllianceBernstein LP increased their stake in the company’s shares by 104.75% in the first quarter, now owning 2,515,562 shares valued at $11.85 million after the acquisition of the additional 4.92 million shares during the last quarter. At the present, 85.20% of HLX shares are in the ownership of institutional investors.

Leave a Comment

Your email address will not be published. Required fields are marked *

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

3 Top Biotech Stocks to Watch

Companies in the biotechnology industry work on the development of drugs and diagnostic technologies to treat medical conditions and diseases. Most Biotech products must undergo